|
|
Volumn 5, Issue 12, 2004, Pages 706-
|
|
New progress in treatment of hormone-refractory prostate cancer
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANDROGEN;
DOCETAXEL;
ESTRAMUSTINE;
HORMONE;
MITOXANTRONE;
PREDNISONE;
PROSTATE SPECIFIC ANTIGEN;
ANALGESIA;
BREAST CANCER;
CANADA;
CANCER PALLIATIVE THERAPY;
CANCER PATIENT;
CANCER STAGING;
CANCER SURVIVAL;
CLINICAL TRIAL;
COLON CANCER;
DRUG EFFICACY;
HUMAN;
LUNG CANCER;
MALE;
MEDICAL DECISION MAKING;
META ANALYSIS;
NOTE;
PRIORITY JOURNAL;
PROSTATE CANCER;
QUALITY OF LIFE;
SIDE EFFECT;
SYSTEMATIC REVIEW;
TREATMENT OUTCOME;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
DRUG RESISTANCE, NEOPLASM;
HUMANS;
MALE;
PAIN;
PROSTATIC NEOPLASMS;
QUALITY OF LIFE;
SURVIVAL ANALYSIS;
TAXOIDS;
TREATMENT OUTCOME;
|
|
EID: 10644294690
PISSN: 14702045
EISSN: None
Source Type: Journal
DOI: 10.1016/S1470-2045(04)01641-9 Document Type: Note |
|
Times cited : (6)
|
|
References (0)
|